Maitreya Medicare Ltd (MAITREYA) — shareholding pattern, promoter holding, financials and share price
About Maitreya Medicare Ltd (MAITREYA)
Maitreya Medicare Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as MAITREYA and on the BSE under scrip code 91877. Its ISIN is INE0PLQ01011.
Incorporated in 2019, Maitreya Medicare Ltd is an integrated multispeciality hospital with primary secondary & tertiary care situated in Surat, Gujrat. [1]
Maitreya Medicare Limited is a multi-specialty hospital established in 2019, based in Surat, Gujarat, with a focus on diverse healthcare services across 18 specialties including cardiology and neurology.
The company has pursued aggressive capacity expansion, establishing new units and partnerships across Gujarat and Maharashtra to broaden their service delivery and patient reach, despite incurring short-term costs.
Listed peers in Hospital: Abate As Industries Ltd, Fortis Malar Hospitals Ltd, Shanmuga Hospital Ltd, Sangani Hospitals Ltd, Aatmaj Healthcare Ltd, Soni Medicare Ltd.
Valuation & Returns
10 Jul 2026At ₹136.35 a share on 10 Jul 2026, Maitreya Medicare Ltd (MAITREYA) was valued at a price-to-earnings ratio of 18.7x against an industry P/E of 61.73x and a price-to-book of 3.46x on a book value of ₹39.43 per share as of Mar 2025. Solomo computes return on equity of 18.49% and return on capital employed of 19.84% from filed results. Earnings ratios use consolidated results for the twelve months Mar 2023 to Mar 2024.
- P/E
- 18.7x
- Industry P/E
- 61.73x
- P/B
- 3.46x
- EPS (TTM)
- ₹7.29
- Book value / share
- ₹39.43
- ROE
- 18.49%
- ROCE
- 19.84%
- ROA
- 10.29%
- Debt / equity
- 0.4x
- Dividend yield
- 0%
- EBITDA margin
- 1.18%
- 52-week range
- ₹133 – ₹292.95
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Maitreya Medicare Ltd (MAITREYA) reported revenue of ₹44.85 crore, net profit of ₹-2.47 crore and earnings per share of ₹-3.65. That compares with revenue of ₹44.98 crore and net profit of ₹1.87 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹21.15 crore and net profit ₹-2.43 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 49.35 | 39.28 | 46.08 | 44.98 | 44.85 |
| Net profit (₹ cr) | 1.14 | 4.25 | 2.97 | 1.87 | -2.47 |
| EPS (₹) | 1,140 | 8.57 | 4.38 | 2.76 | -3.65 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 39.52% | -2.69% | -2.30% |
| Profit growth | - | 21.26% | -37.04% |
| Stock price CAGR | - | - | -54% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 73.11% of Maitreya Medicare Ltd (MAITREYA). Market capitalisation was ₹92 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2024.
Largest disclosed public shareholders in Mar 2026: South Gujarat Shares And Sharebrokers Limited 2.76%, Hashim Yacoobali 1.02%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 73.11% | - | - | - | - |
| Sep 2025 | 73.11% | - | - | - | - |
| Mar 2025 | 73.11% | - | - | - | - |
| Sep 2024 | 73.11% | - | - | - | - |
| Mar 2024 | 73.11% | - | - | - | - |